Saturday, July 11, 2026

pharma · Adenocarcinoma of Lung · Primary Sjögren's Syndrome

Peking University Biologics

Peking University Biologics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
2018 Founded
8 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
2018
Employees
8
Programs
2
Drugs
2
Patents
0
Intelligence · Clinical Programs

Peking University Biologics projects

0 ClinicalTrials.gov programs sponsored by Peking University Biologics.

Peking University Biologics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Peking University Biologics have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.